EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination

Andrew R Kick iD, Alicyn F Grete, Elisa Crisci iD, Glen W Almond, Tobias Käser iD

Vaccines · 05.03.2023 · 11 (3) · 594

DOI: 10.3390/vaccines11030594 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 05.03.2023. Verfasst von Andrew R Kick und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Army.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome virus (PRRSV) is an on-going problem for the worldwide pig industry. Commercial and experimental vaccinations often demonstrate reduced pathology and improved growth performance; however, specific immune correlates of protection (CoP) for PRRSV vaccination have not been quantified or even definitively postulated: proposing CoP for evaluation during vaccination and challenge studies will benefit our collective efforts towards achieving protective immunity. Applying the breadth of work on human diseases and CoP to PRRSV research, we advocate four hypotheses for peer review and evaluation as appropriate testable CoP: (i) effective class-switching to systemic IgG and mucosal IgA neutralizing antibodies is required for protective immunity; (ii) vaccination should induce virus-specific peripheral blood CD4+ T-cell proliferation and IFN-γ production with central memory and effector memory phenotypes; cytotoxic T-lymphocytes (CTL) proliferation and IFN-γ production with a CCR7- phenotype that should migrate to the lung; (iii) nursery, finishing, and adult pigs will have different CoP; (iv) neutralizing antibodies provide protection and are rather strain specific; T cells confer disease prevention/reduction and possess greater heterologous recognition. We believe proposing these four CoP for PRRSV can direct future vaccine design and improve vaccine candidate evaluation.

Schlagwörter

Stichwörter der Autor:innen

IFN-γIgGPRRSVT cellcorrelates of protectionhumoral immunityneutralizing antibodiesvaccination

Autor:innen und Institutionen

  • Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
  • Department of Chemistry & Life Science, United States Military Academy, West Point, NY 10996, USA.
  • Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.

ORCID-Profile: Andrew R Kick, Elisa Crisci, Tobias Käser

Förderung

  • United States Army

Zitieren

APA

Kick, A. R., Grete, A. F., Crisci, E., Almond, G. W., & Käser, T. (2023). Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination. Vaccines, 11(3), 594. https://doi.org/10.3390/vaccines11030594

Vancouver

Kick AR, Grete AF, Crisci E, Almond GW, Käser T. Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination. Vaccines. 2023;11(3):594. doi:10.3390/vaccines11030594

BibTeX
@article{Kick2023,
  author = {Kick, Andrew R and Grete, Alicyn F and Crisci, Elisa and Almond, Glen W and Käser, Tobias},
  title = {Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {594},
  doi = {10.3390/vaccines11030594}
}
Kostenlos starten →